LDDD Longduoduo Co Ltd
Services-Health Services · OTC · SEC CIK 1892316 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY-71.6%
TTM net income YoY-316.7%
TTM EPS YoY-321.4%
Revenue 3-yr CAGR-38.1%
Net income 3-yr CAGR—
Margins
Gross margin99.1%
Operating margin-88.5%
Net margin-78.3%
FCF margin—
EBITDA margin-79.1%
Returns
ROE-132.6%
ROA-53.9%
ROIC (approx.)—
Asset turnover0.69x
Leverage & solvency
Liabilities / assets80.2%
Debt / equity0.00x
Current ratio1.07x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.44x
Accruals ratio-30.3%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q12026-09-30 | 2026Q4*2026-06-30 | 2026Q32026-03-31 | 2026Q22025-12-31 | 2026Q12025-09-30 | 2025Q4*2025-06-30 | 2025Q32025-03-31 | 2025Q22024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $17,595 | $631,036 | $187,392 | $345,265 | $658,764 | $940,376 | $777,720 | $1.78M |
| Cost of revenue | — | $1,640 | $3,337 | $5,271 | $6,710 | $9,598 | $20,444 | $28,781 |
| Gross profit | $17,595 | $629,396 | $184,055 | $339,994 | $652,054 | $930,778 | $757,276 | $1.75M |
| SG&A expense | $513,930 | $701,527 | $381,498 | $619,187 | $736,468 | $799,778 | $876,095 | $1.14M |
| Operating income | -$496,335 | -$72,131 | -$197,443 | -$279,193 | -$84,414 | $131,000 | -$118,819 | $602,574 |
| Pretax income | -$478,845 | -$67,537 | -$189,966 | -$274,225 | -$44,088 | $282,093 | -$116,236 | $607,995 |
| Income tax | -$4,678 | -$704 | $41 | $20 | $67,094 | $115,608 | $84 | $106,396 |
| Net income | -$436,962 | -$62,974 | -$166,208 | -$258,495 | -$90,954 | $163,145 | -$109,104 | $463,697 |
| EBITDA | -$468,409 | -$43,982 | -$169,588 | -$251,955 | -$56,992 | $158,087 | -$91,158 | $655,118 |
| EPS (basic) | -0.01 | — | -0.01 | -0.01 | -0.00 | — | -0.00 | 0.02 |
| EPS (diluted) | -0.01 | — | -0.01 | -0.01 | -0.00 | — | -0.00 | 0.02 |
| Weighted avg. shares (diluted) | 30.02M | — | 30.02M | 30.02M | 30.02M | — | 30.01M | 30.01M |
| Balance sheet | ||||||||
| Cash & equivalents | $1.01M | $1.59M | $1.22M | $1.54M | $1.25M | $1.64M | $1.46M | $1.62M |
| Current assets | $1.29M | $1.78M | $1.44M | $1.76M | $1.52M | $1.81M | $1.69M | $1.83M |
| PP&E, net | $187,751 | $213,025 | $237,358 | $261,850 | $284,387 | $280,003 | $300,179 | $325,426 |
| Total assets | $1.53M | $2.06M | $1.75M | $2.10M | $1.90M | $2.13M | $2.03M | $2.20M |
| Current liabilities | $1.21M | $1.28M | $932,776 | $1.12M | $677,352 | $830,464 | $901,763 | $972,258 |
| Total liabilities | $1.23M | $1.31M | $957,123 | $1.14M | $700,555 | $830,464 | $920,639 | $990,851 |
| Shareholders' equity | $288,107 | $703,691 | $736,924 | $880,361 | $1.11M | $1.18M | $998,047 | $1.09M |
| Shares outstanding | 30.02M | 30.02M | 30.02M | 30.02M | 30.02M | 30.02M | 30.02M | 30.01M |
| Cash flow statement | ||||||||
| Operating cash flow | -$615,031 | $274,772 | -$332,309 | $268,612 | -$374,184 | $184,215 | -$187,111 | $815,259 |
| Capital expenditure | — | $275 | $275 | $140 | $29,948 | $29,921 | -$26,852 | -$125 |
| Free cash flow | — | $274,497 | -$332,584 | $268,472 | -$404,132 | $154,294 | -$160,259 | $815,384 |
| Investing cash flow | — | -$275 | -$275 | -$140 | -$29,948 | -$29,921 | $26,852 | $125 |
| Depreciation & amortization | $27,926 | $28,149 | $27,855 | $27,238 | $27,422 | $27,087 | $27,661 | $52,544 |
Free plan shows the latest 8 periods; Pro shows all 21 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.